rs201502372

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_212550.5(BLOC1S3):​c.478G>A​(p.Val160Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000719 in 1,391,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V160L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

BLOC1S3
NM_212550.5 missense

Scores

1
4
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.22

Publications

7 publications found
Variant links:
Genes affected
BLOC1S3 (HGNC:20914): (biogenesis of lysosomal organelles complex 1 subunit 3) This gene encodes a protein that is a component of the BLOC1 multi-subunit protein complex. This complex is necessary for the biogenesis of specialized organelles of the endosomal-lysosomal system, including platelet dense granules and melanosomes. Mutations in this gene cause Hermansky-Pudlak syndrome 8, a disease characterized by lysosomal storage defects, bleeding due to platelet storage pool deficiency, and oculocutaneous albinism. [provided by RefSeq, Jul 2008]
MARK4 (HGNC:13538): (microtubule affinity regulating kinase 4) This gene encodes a member of the microtubule affinity-regulating kinase family. These protein kinases phosphorylate microtubule-associated proteins and regulate the transition between stable and dynamic microtubules. The encoded protein is associated with the centrosome throughout mitosis and may be involved in cell cycle control. Expression of this gene is a potential marker for cancer, and the encoded protein may also play a role in Alzheimer's disease. Pseudogenes of this gene are located on both the short and long arm of chromosome 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
MARK4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.204371).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BLOC1S3NM_212550.5 linkc.478G>A p.Val160Met missense_variant Exon 2 of 2 ENST00000433642.3 NP_997715.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BLOC1S3ENST00000433642.3 linkc.478G>A p.Val160Met missense_variant Exon 2 of 2 2 NM_212550.5 ENSP00000393840.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.19e-7
AC:
1
AN:
1391778
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
689778
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
28912
American (AMR)
AF:
0.00
AC:
0
AN:
35812
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24292
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33948
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80402
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40970
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5546
European-Non Finnish (NFE)
AF:
9.22e-7
AC:
1
AN:
1084256
Other (OTH)
AF:
0.00
AC:
0
AN:
57640
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.0060
T
BayesDel_noAF
Benign
-0.25
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T;T;T
Eigen
Benign
0.13
Eigen_PC
Benign
0.099
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.65
.;T;T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.20
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N;.
PhyloP100
2.2
PrimateAI
Pathogenic
0.96
D
PROVEAN
Benign
-0.95
N;.;.
REVEL
Benign
0.14
Sift
Uncertain
0.012
D;.;.
Sift4G
Uncertain
0.030
D;D;D
Polyphen
1.0
D;D;.
Vest4
0.33
MutPred
0.18
Gain of catalytic residue at V160 (P = 0.0266);Gain of catalytic residue at V160 (P = 0.0266);.;
MVP
0.19
MPC
1.8
ClinPred
0.74
D
GERP RS
2.2
PromoterAI
-0.0015
Neutral
Varity_R
0.088
gMVP
0.30
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201502372; hg19: chr19-45683032; API